Parabilis Medicines Inc
NASDAQ:PBLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Parabilis Medicines Inc
NASDAQ:PBLS
|
US |
|
M
|
Mandrake Resources Ltd
ASX:MAN
|
AU |
|
G
|
GSR III Acquisition Corp
NASDAQ:GSRT
|
US |
|
G
|
Gold Pacific Co Ltd
KOSDAQ:038530
|
KR |
|
Chancellor Group Inc
OTC:CHAG
|
US |
|
I
|
International Card Establishment Inc
OTC:ICRD
|
US |
|
H
|
Human Technologies Inc
TSE:5621
|
JP |
|
B
|
Black Dragon Resource Companies Inc
OTC:BDGR
|
US |
|
Terra Balcanica Resources Corp
OTC:TEBAF
|
CA |
|
Andfjord Salmon AS
F:50R
|
NO |
|
U
|
UVAT Technology Co Ltd
TPEX:3580
|
TW |
|
Liquid Media Group Ltd
OTC:YVRLF
|
CA |
|
McCoy Global Inc
F:773
|
CA |
|
F
|
Fountainhall Capital Corp
XTSX:FUN.P
|
CA |
|
Contango Asset Management Ltd
ASX:CGA
|
AU |
Shareholder Yield
Current shareholder yield for PBLS is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PBLS Price
Parabilis Medicines Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -21% |
| Market Capitalization | 4.8B USD |
| Shares Outstanding | 118 145 780 |
| Percentage of Shares Shorted | 2.29% |
